Circulating levels of VEGF-C and the soluble form of its cognate receptor, soluble VEGFR-3, were measured in two well-characterized SSc cohorts and were found to be predictive of the development of PAH, suggesting that lymphangiogenesis is deregulated during PAH development [50]. This evidence concerns the gene FLT4 and systemic sclerosis.